Literature DB >> 12065781

Erdheim-Chester disease: case report, PCR-based analysis of clonality, and review of literature.

Samer Al-Quran1, John Reith, John Bradley, Lisa Rimsza.   

Abstract

Erdheim-Chester disease (ECD) is a rare, distinct clinicopathologic entity with nearly pathognomonic radiographic features. The lesions consist of lipid-storing CD68 (+), CD1a (-) non-Langerhans' cell histiocytes, either localized to the bone or involving multiple organ systems in the body. Whether these histiocytic proliferations represent monoclonal neoplastic populations or are part of a polyclonal reactive process is unclear. We present a case report of ECD in a 35-year-old African-American woman with a progressive course over 6 years. We investigated the clonality of the histiocytes using the HUMARA assay on paraffin-embedded tissue sections but did not find any evidence that these cells represent a monoclonal population. In this report, the characteristics of ECD are reviewed, the genetic basis of the HUMARA assay is discussed, and our results in the context of other clonality investigations reported in the literature to date are summarized.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12065781     DOI: 10.1038/modpathol.3880583

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  19 in total

1.  Erdheim-Chester disease of the breast associated with Langerhans-cell histiocytosis of the hard palate.

Authors:  V P Andrade; C C V Nemer; A N L Prezotti; W S L Goulart
Journal:  Virchows Arch       Date:  2004-08-24       Impact factor: 4.064

Review 2.  [Erdheim-Chester disease and Rosai-Dorfman disease: Pathological, radiological and clinical features of adult non-Langerhans cell histiocytosis].

Authors:  H Bösmüller; D Nann; M Horger; F Fend
Journal:  Pathologe       Date:  2015-09       Impact factor: 1.011

Review 3.  Erdheim-Chester Disease: a comprehensive review of the literature.

Authors:  Roei D Mazor; Mirra Manevich-Mazor; Yehuda Shoenfeld
Journal:  Orphanet J Rare Dis       Date:  2013-09-08       Impact factor: 4.123

4.  Treatment of skeletal Erdheim-Chester disease with zoledronic acid: case report and proposed mechanisms of action.

Authors:  Thitinan Srikulmontree; H Davis Massey; W Neal Roberts
Journal:  Rheumatol Int       Date:  2006-08-25       Impact factor: 2.631

5.  Unusual presentation of Erdheim-Chester disease in a child with acute lymphoblastic leukemia.

Authors:  Archana George Vallonthaiel; Asit Ranjan Mridha; Shivanand Gamanagatti; Manisha Jana; Mehar Chand Sharma; Shah Alam Khan; Sameer Bakhshi
Journal:  World J Radiol       Date:  2016-08-28

Review 6.  Pathological consequence of misguided dendritic cell differentiation in histiocytic diseases.

Authors:  Marie-Luise Berres; Carl E Allen; Miriam Merad
Journal:  Adv Immunol       Date:  2013       Impact factor: 3.543

Review 7.  Erdheim-Chester disease presenting with cutaneous involvement: a case report and literature review.

Authors:  Elgida Radoncipi Volpicelli; Leona Doyle; Justin P Annes; Michael F Murray; Eric Jacobsen; George F Murphy; Arturo P Saavedra
Journal:  J Cutan Pathol       Date:  2010-12-12       Impact factor: 1.587

8.  An unusual case of Erdheim-Chester disease with features of Langerhans cell histiocytosis.

Authors:  Paul S Furmanczyk; James D Bruckner; Thurman Gillespy; Brian P Rubin
Journal:  Skeletal Radiol       Date:  2007-05-11       Impact factor: 2.199

9.  Erdheim-Chester disease: an unusual presentation of an uncommon disease.

Authors:  Jasjeet Bindra; Alexander Lam; Ramit Lamba; Michael VanNess; Robert D Boutin
Journal:  Skeletal Radiol       Date:  2013-12-24       Impact factor: 2.199

10.  Erdheim-Chester disease: a case report.

Authors:  Esther M Hoffmann; Wibke Müller-Forell; Susanne Pitz; Herbert Radner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-09       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.